Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes-Reference-Cited by-同舟云学术

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

Published:2017 Issue:1 Volume:22 Page:15
ISSN:2287-1012
Container-title:Annals of Pediatric Endocrinology & Metabolism
language:en
Short-container-title:Ann Pediatr Endocrinol Metab

Author:

Lee Seungah¹,Lee Dong Yun¹²^ORCID

Affiliation:

1. Department of Bioengineering, College of Engineering, and BK21 PLUS Future Biopharmaceutical Human Resources Training and Research Team, Hanyang University, Seoul, Korea.

2. Institute of Nano Science & Technology (INST), Hanyang University, Seoul, Korea.

Funder

National Research Foundation of Korea

Publisher

Korean Society of Pediatric Endocrinology

Subject

Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health

Link

https://synapse.koreamed.org/pdf/10.6065/apem.2017.22.1.15

Reference99 articles.

1. A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond

2. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

3. Aace Comprehensive Diabetes Management Algorithm 2013

4. Biology of Incretins: GLP-1 and GIP

5. Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potential of Various Intermittent Fasting Regimens in Alleviating Type 2 Diabetes Mellitus and Prediabetes: A Narrative Review;Nutrients;2024-08-14

2. Machine-Learning-Guided Peptide Drug Discovery: Development of GLP-1 Receptor Agonists with Improved Drug Properties;Journal of Medicinal Chemistry;2024-07-08

3. GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for CombatingAlzheimer’s Disease through its Supporting DPP4 Inhibitors: A Review;Current Topics in Medicinal Chemistry;2024-07

4. Pharmacotherapy of Weight‐loss and Obesity with a Focus on GLP 1‐Receptor Agonists;The Journal of Clinical Pharmacology;2024-06-26

5. The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer;Cancer and Metastasis Reviews;2024-05-27